During the past decade, Phase I Clinical Trial Centre, Chinese University of Hong Kong conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phase I Clinical Trial Centre, Chinese University of Hong Kong" #1 collaborator was "Chinese University of Hong Kong" with 2 trials as a collaborator and "Zhaoke (Guangzhou) Pharmaceutical Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Phase I Clinical Trial Centre, Chinese University of Hong Kong" are "Healthy" (2 trials), "Bioequivalence of Two Azilsartan Formulations" (1 trials) and "Depression" (1 trials). Many other conditions were trialed in "Phase I Clinical Trial Centre, Chinese University of Hong Kong" in a lesser frequency.

Most popular intervention types in "Phase I Clinical Trial Centre, Chinese University of Hong Kong" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Azilsartan (Takeda)" (1 trials), "Azilsartan (Zhaoke)" (1 trials), "BF-Methyldopa 250mg Tablet" (1 trials), "Fortolin Tab 500mg" (1 trials) and "Metopa Tab 250mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Phase I Clinical Trial Centre, Chinese University of Hong Kong" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Phase I Clinical Trial Centre, Chinese University of Hong Kong". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Phase I Clinical Trial Centre, Chinese University of Hong Kong, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Phase I Clinical Trial Centre, Chinese University of Hong Kong, 4 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".